<scp>CIDP</scp> Treatment Outcomes Correlation With First Nerve Conduction Changes: Ascertainment of Initial and Long‐Term Responders
The first change in fibular CMAP amplitude is a reliable biomarker for predicting CIDP treatment response, with ulnar and summated CMAP amplitudes as alternatives when the fibular response is absent. Our findings highlight the utility of first NCS changes in monitoring and predicting treatment outcomes in CIDP.
Authors
- Marcus Vinícius Pinto (ORCID: https://orcid.org/0000-0002-9890-6657)
- Natthapon Rattanathamsakul (ORCID: https://orcid.org/0000-0002-1698-0520)
- JR Dyck
- Divyanshu Dubey (ORCID: https://orcid.org/0000-0001-6865-9045)
- Grace Swart (ORCID: https://orcid.org/0000-0003-0661-7776)
- Michelle L. Mauermann (ORCID: https://orcid.org/0000-0001-9619-7802)
- Thapat Wannarong (ORCID: https://orcid.org/0000-0003-1839-1903)
- Kamal Shouman (ORCID: https://orcid.org/0000-0003-0626-4835)
- Michael Skolka (ORCID: https://orcid.org/0009-0006-5155-4371)
- Sarah E. Berini (ORCID: https://orcid.org/0009-0005-5988-4255)
- Christopher J. Klein (ORCID: https://orcid.org/0000-0002-4012-8856)
- Nathan P. Staff (ORCID: https://orcid.org/0000-0001-6760-3859)
- Anthony J. Windebank
Institutions
- Mayo Clinic (US)
- Siriraj Hospital (TH)
- Mahidol University (TH)
Publication Details
- Journal
- Journal of the Peripheral Nervous System
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1111/jns.70017
- Citations
- 1
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39